174
Views
6
CrossRef citations to date
0
Altmetric
Review

Endoscopic resection for gastrointestinal neuroendocrine tumors

, , , , , & show all
Pages 559-569 | Published online: 10 Jan 2014

References

  • Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the diffuse neuroendocrine system. Curr. Opin. Oncol. 20, 1–12 (2008).
  • Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 128(6), 1717–1751 (2005).
  • Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr. Rev. 25(3), 458–511 (2004).
  • Modlin IM, Shapiro MD, Kidd M. Siegfried Oberndorfer: origins and perspectives of carcinoid tumors. Hum. Pathol. 35, 1440–1451 (2004).
  • Gustafsson BI, Hauso O, Drozdov I, Kidd M, Modlin IM. Carcinoid heart disease. Int. J. Cardiol. 129, 318–324 (2008).
  • Yao JC, Hassan M, Phan A et al. One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 26(18), 3063–3072 (2008).
  • Yamagishi H. Early diagnosis and successful treatment of small-intestinal carcinoid tumor: useful combination of capsule endoscopy and double-balloon endoscopy. Endoscopy 39(Suppl 1), E243–E244 (2007).
  • Stridsberg M, Oberg K, Li Q, Engström U, Lundqvist G. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J. Endocrinol. 144, 49–59 (1995).
  • Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J. Surg. Oncol. 89, 151–160 (2005).
  • Sciarra A, Monti S, Gentile V et al. Chromogranin A expression in familial versus sporadic prostate cancer. Urology 66, 1010–1014 (2005).
  • Syversen U, Ramstad H, Gamme K et al. Clinical significance of elevated serum chromogranin A levels. Scand. J. Gastroenterol. 39, 969–973 (2004).
  • Rösch T, Kapfer B, Will U et al.; Accuracy of endoscopic ultrasonography in upper gastrointestinal submucosal lesions: a prospective multicenter study. Scand. J. Gastroenterol. 37(7), 856–862 (2002).
  • Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann. N. Y. Acad. Sci. 1014, 13–27 (2004).
  • Oberg K, Castellano D. Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metastasis Rev. 30(Suppl 1), 3–7 (2011).
  • Kulke MH, Anthony LB, Bushnell DL et al.; NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39(6), 735–752 (2010).
  • Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 39, 707–712 (2010).
  • Klimstra DS, Modlin IR, Adsay NV et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am. J. Surg. Pathol. 34, 300–313 (2010).
  • Eller R F. Gastrointestinal carcinoid tumors. Am. Surg. 57(7), 434–437 (1991).
  • Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 103(8), 1587–1595 (2005).
  • Soga J. Carcinoids of the rectum: an evaluation of 1271 reported cases. Surg. Today 27(2), 112–119 (1997).
  • Mashimo Y, Matsuda T, Uraoka T et al. Endoscopic submucosal resection with a ligation device is an effective and safe treatment for carcinoid tumors in the lower rectum. J. Gastroenterol. Hepatol. 23(2), 218–221 (2008).
  • Ono A, Fujii T, Saito Y et al. Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device. Gastrointest. Endosc. 57(4), 583–587 (2003).
  • Nagai T, Torishima R, Nakashima H et al. Saline-assisted endoscopic resection of rectal carcinoids: cap aspiration method versus simple snare resection. Endoscopy 36(3), 202–205 (2004).
  • Higashino K, Iishi H, Narahara H et al. Endoscopic resection with a two-channel videoendoscope for gastric carcinoid tumors. Hepatogastroenterology 51(55), 269–272 (2004).
  • Ichikawa J, Tanabe S, Koizumi W et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 35(3), 203–206 (2003).
  • Hopper AD, Bourke MJ, Hourigan LF, et al. En-bloc resection of multiple type 1 gastric carcinoid tumors by endoscopic multi-band mucosectomy. J. Gastroenterol. Hepatol. 24(9), 1516–1521 (2009).
  • Lee DS, Jeon SW, Park SY et al. The feasibility of endoscopic submucosal dissection for rectal carcinoid tumors: comparison with endoscopic mucosal resection. Endoscopy 42(8), 647–651 (2010).
  • Fujishiro M, Yahagi N, Nakamura M et al. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest. Endosc. 63(2), 243–249 (2006).
  • Onozato Y, Kakizaki S, Ishihara H et al. Endoscopic submucosal dissection for rectal tumors. Endoscopy 39(5), 423–427 (2007).
  • Kantsevoy SV, Adler DG, Conway JD et al.; Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest. Endosc. 68(1), 11–18 (2008).
  • Abe T, Kakemura T, Fujinuma S, Maetani I. Successful outcomes of EMR-L with 3D-EUS for rectal carcinoids compared with historical controls. World J. Gastroenterol. 14(25), 4054–4058 (2008).
  • Yamamoto H, Kawata H, Sunada K et al. Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood. Endoscopy 35(8), 690–694 (2003).
  • Ono H, Kondo H, Gotoda T et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48(2), 225–229 (2001).
  • Rösch T, Sarbia M, Schumacher B et al. Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy 36(9), 788–801 (2004).
  • Gotoda T, Kondo H, Ono H et al. A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest. Endosc. 50(4), 560–563 (1999).
  • Larghi A, Waxman I. State of the art on endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest. Endosc. Clin. N. Am. 17(3), 441–469, (2007).
  • Yamamoto H, Yube T, Isoda N et al. A novel method of endoscopic mucosal resection using sodium hyaluronate. Gastrointest. Endosc. 50(2), 251–256 (1999).
  • Fujishiro M, Yahagi N, Kashimura K et al. Different mixtures of sodium hyaluronate and their ability to create submucosal fluid cushions for endoscopic mucosal resection. Endoscopy 36(7), 584–589 (2004).
  • Fujishiro M, Yahagi N, Kashimura K et al. Comparison of various submucosal injection solutions for maintaining mucosal elevation during endoscopic mucosal resection. Endoscopy 36(7), 579–583 (2004).
  • Lee SH, Park JH, Park do H et al. Clinical efficacy of EMR with submucosal injection of a fibrinogen mixture: a prospective randomized trial. Gastrointest. Endosc. 64(5), 691–696 (2006).
  • Hyun JJ, Chun HR, Chun HJ et al. Comparison of the characteristics of submucosal injection solutions used in endoscopic mucosal resection. Scand. J. Gastroenterol. 41, 488–492 (2006).
  • Kishihara T, Chino A, Uragami N et al. Usefulness of sodium hyaluronate solution in colorectal endoscopic mucosal resection. Dig. Endosc. 24(5), 348–352 (2012).
  • Matsui Y et al. Hyaluronic acid stimulates tumor-cell proliferation at wound sites. Gastrointes Endosc. 60(4), 539–543 (2004).
  • Sohn DK, Chang HJ, Choi HS et al. Does hyaluronic acid stimulate tumor growth after endoscopic mucosal resection? J. Gastroenterol. Hepatol. 23(8 Pt 1), 1204–1207 (2008).
  • Giday SA, Magno P, Buscaglia JM et al. Is blood the ideal submucosal cushioning agent? A comparative study in a porcine model. Endoscopy 38(12), 1230–1234 (2006).
  • Al-Taie OH, Bauer Y, Dietrich CG, Fischbach W. Efficacy of submucosal injection of different solutions inclusive blood components on mucosa elevation for endoscopic resection. Clin. Exp. Gastroenterol. 5, 43–48 (2012).
  • Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: clarifying these clinical conundrums. World J. Surg. 29(1), 92–101 (2005).
  • Ready AR, Soul JO, Newman J, Matthews HR. Malignant carcinoid tumour of the oesophagus. Thorax 44(7), 594–596 (1989).
  • Babich JP. Endoscopic mucosal resection of a mid-esophageal carcinoid with EUS guidance. Endoscopy 42(Suppl 2), e302–e303 (2010).
  • Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 104(4), 994–1006 (1993).
  • Delle Fave G, Capurso G, Milione M, Panzuto F. Endocrine tumours of the stomach. Best Pract. Res. Clin. Gastroenterol. 19, 659–673 (2005).
  • Borch K, Ahrén B, Ahlman H, et al. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann. Surg. 242(1), 64–73 (2005).
  • Nakata K, Aishima S, Ichimiya H et al. Unusual multiple gastric carcinoids with hypergastrinemia: report of a case. Surg. Today 40, 267–271 (2010).
  • Rindi G. Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. Gastroenterol. Clin. North Am. 36(4), 267–271, (2007).
  • Kekili M. Endoscopic and pathological aspects of gastric polyps: a Turkish referral center study. Hepatogastroenterology 59(116), 1147–1149 (2012).
  • Jianu CS. Gastric carcinoid after long term use of a proton pump inhibitor. Aliment Pharmacol. Ther. 36(7), 644–649 (2012).
  • Arnold R. Carcinoid tumors. Presented at: International symposium on pathology, epidemiology, clinical aspects and therapy. Munich, Germany, 13–16 January 1994.
  • Spampatti MP, Massironi S, Rossi RE et al. Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature. Eur. J. Gastroenterol Hepatol 24(5), 589–593 (2012).
  • Modlin IM, Tang LH. The gastric enterochromaffin-like cell: an enigmatic cellular link. Gastroenterology 111(3), 783–810 (1996).
  • Merola E, Sbrozzi-Vanni A, Panzuto F et al. Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology 95(3), 207–213 (2012).
  • Saund MS, Al Natour RH, Sharma AM, et al. Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids. Ann. Surg. Oncol. 18(10), 2826–2832 (2011).
  • Meko JB, Norton JA. Management of patients with Zollinger-Ellison syndrome. Annu. Rev. Med. 46, 395–411 (1995).
  • Bordi C, Yu JY, Baggi MT et al. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 67(3), 663–672 (1991).
  • Strosberg JR, Coppola D, Klimstra DS et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas 39(6), 799–800 (2010).
  • Kim BS, Oh ST, Yook JH et al. Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses. Am. J. Surg. 200(3), 328–333 (2010).
  • Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 79(4), 813–829 (1997).
  • Ruszniewski P, Delle Fave G, Cadiot G et al. Well-differentiated gastric tumors/carcinomas. Neuroendocrinology 84(3), 158–164 (2006).
  • Shimizu N, Kaminishi M. Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum. Nippon Geka Gakkai Zasshi. 109(3), 147–151 (2008).
  • Nikou GC, Toubanakis C, Moulakakis KG et al. Carcinoid tumors of the duodenum and the ampulla of Vater: current diagnostic and therapeutic approach in a series of 8 patients. Case series. Int. J. Surg. 9, 248–253 (2011).
  • Bordi C. Gastrointestinal endocrine tumors: recent developments. Endocrine Pathology 9(2), 99–115 (1998).
  • Pipeleers-Marichal M, Donow C, Heitz PU, Klöppel G. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I. World J. Surg. 17(4), 481–488 (1993).
  • Donow C, Pipeleers-Marichal M, Schröder S, et al. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer 68(6), 1329–1334 (1991).
  • Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig EB. Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch. Pathol. Lab. Med. 114, 700–704 (1990).
  • Baum RP, Prasad V, Hommann M, Hörsch D. Receptor PET/CT imaging of neuroendocrine tumors. Recent Results Cancer Res. 170, 225–242 (2008).
  • Karagiannis S. Endoscopic resection with the cap technique of a carcinoid tumor in the duodenal bulb. Endoscopy 41, 288–289 (2009).
  • Dalenbäck J, Havel G. Local endoscopic removal of duodenal carcinoid tumors. Endoscopy 36, 651–655 (2004).
  • Tai WP, Yue H. Endoscopic mucosa resection of a duodenum carcinoid tumor of 1.2 cm diameter: a case report. Med. Oncol. 26, 319–321 (2009).
  • Honda T, Yamamoto H, Osawa H et al. Endoscopic submucosal dissection for superficial duodenal neoplasms. Dig. Endosc. 21, 270–274 (2009).
  • Matsumoto S, Miyatani H, Yoshida Y, Nokubi M. Duodenal carcinoid tumors: 5 cases treated by endoscopic submucosal dissection. Gastrointest. Endosc. 74(5), 1152–1156 (2011).
  • Hartel M, Wente MN, Sido B, Friess H, Büchler MW. Carcinoid of the ampulla of Vater. J. Gastroenterol. Hepatol. 20(5), 676–681 (2005).
  • De Palma GD, Masone S, Siciliano S et al. Endocrine carcinoma of the major papilla: report of two cases and review of the literature. Surg. Oncol. 19, 235–242 (2010).
  • Yi H. Successful en bloc resection of papillary neuroendocrine tumors by duodenoscope using endoscopic submucosal dissection method. Clin. Res. Hepatol. Gastroenterol. 36(5), e100–e103 (2012).
  • Albizzatti V, Casco C, Gastaminza M et al. Endoscopic resection of two duodenal carcinoid tumors. Endoscopy 32(7), S42 (2000).
  • Kim MH, Lee SK, Seo DW et al. Tumors of the major duodenal papilla. Gastrointest. Endosc. 54(5), 609–620 (2001).
  • Niido T. Carcinoid of major duodenal papilla. Gastrointest. Endosc. 61(1), 106–107 (2005).
  • Kefalas CH et al. Endoscopic electrosurgical snare resection of leiomyosarcoma of main duodenal papilla. Gastrointest. Endosc. 70, 592–595 (2004).
  • Fukushima H. Complete en bloc resection of large ampullary adenoma with focal adenocarcinoma by using endoscopic submucosal dissection. Gastrointest. Endosc. 64, 877–883 (2006)
  • Oka S, Tanaka S, Kaneko I et al. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest. Endosc. 64, 877–883 (2006).
  • Marshall JB, Bodnarchuk G. Carcinoid tumors of the gut. Our experience over three decades and review of the literature. J. Clin. Gastroenterol. 16(2), 123–129 (1993).
  • Burke AP, Thomas RM, Elsayed AM, Sobin LH. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 79(6), 1086–1093 (1997).
  • Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4), 934–959 (2003).
  • Kulke MH, Mayer RJ. Carcinoid tumors. N. Engl. J. Med. 340(11), 858–868 (1999).
  • Crocetti E, Paci E. Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological srudy with 6830 cases. Eir. J. Cancer Prev. 12, 191–194 (2003).
  • Boudreaux JP, Klimstra DS, Hassan MM et al.; The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas 39(6), 753–766 (2010).
  • Anthony LB, Strosberg JR, Klimstra DS et al.; The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas 39(6), 767–774 (2010).
  • Scherübl H. Rectal carcinoids are on the rise: early detection by screening endoscopy. Endoscopy 41, 162–165 (2009).
  • Mani S, Modlin IM, Ballantyne G, Ahlman H, West B. Carcinoids of the rectum. J. Am. Coll. Surg. 179(2), 231–248 (1994).
  • Jetmore AB, Ray JE, Gathright JB et al. Rectal carcinoids: the most frequent carcinoid tumor. Dis. Colon Rectum 35(8), 717–725 (1992).
  • Park CH, Cheon JH, Kim JO et al. Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread. Endoscopy 43, 790–795 (2011).
  • Son HJ, Sohn DK, Hong CW et al. Factors associated with complete local excision of small rectal carcinoid tumor. Int. J. Colorectal Dis. (2012) (Epub ahead of print).
  • Iishi H, Tatsuta M, Yano H et al. More effective endoscopic resection with a two-channel colonoscope for carcinoid tumors of the rectum. Dis. Colon Rectum 39(12), 1438–1439 (1996).
  • Zhao ZF, Zhang N, Ma SR et al. A comparative study on endoscopy treatment in rectal carcinoid tumors. Surg. Laparosc. Endosc. Percutan. Tech. 22(3), 260–263 (2012).
  • Kim KM, Eo SJ, Shim SG et al. Treatment outcomes according to endoscopic treatment modalities for rectal carcinoid tumors. Clin. Res. Hepatol. Gastroenterol. 37(3), 275–282 (2012).
  • Kakushima N, Fujishiro M. Endoscopic submucosal dissection for gastrointestinal neoplasms. World J. Gastroenterol. 14(19), 2962–2967 (2008).
  • Minami S, Gotoda T, Ono H, Oda I, Hamanaka H. Complete endoscopic closure of gastric perforation induced by endoscopic resection of early gastric cancer using endoclips can prevent surgery (with video). Gastrointest. Endosc. 63, 596–601 (2006).
  • Fujishiro M, Yahagi N, Kakushima N et al. Successful nonsurgical management of perforation complicating endoscopic submucosal dissection of gastrointestinal epithelial neoplasms. Endoscopy 38, 1001–1006 (2006).
  • Oyama T, Tomori A, Hotta K et al. Endoscopic submucosal dissection of early esophageal cancer. Clin. Gastroenterol. Hepatol. 3, S67–S70 (2005).
  • Fujishiro M, Yahagi N, Kakushima N et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin. Gastroenterol. Hepatol. 4, 688–694 (2006).
  • Fujishiro M, Yahagi N, Kakushima N et al. En bloc resection of a large semicircular esophageal cancer by endoscopic submucosal dissection. Surg. Laparosc. Endosc. Percutan. Tech. 16(4), 237–241 (2006).
  • Singh P, Das A, Isenberg G et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest. Endosc. 60(4), 544–550 (2004).
  • Honig LJ, Weingarten G. A gastric carcinoid tumor with massive bleeding. Am. J. Gastroenterol. 61(1), 40–44 (1974).
  • Parris WC, Oates JA, Kambam J, Shmerling R, Sawyers JF. Pre-treatment with somatostatin in the anaesthetic management of a patient with carcinoid syndrome. Can. J. Anaesth. 35(4), 413–416 (1988).
  • Quinlivan JK, Roberts WA. Intraoperative octreotide for refractory carcinoid-induced bronchospasm. Anesth. Analg. 78(2), 400–402 (1994).
  • Claure RE, Drover DD, Haddow GR, Esquivel CO, Angst MS. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management. Can. J. Anaesth. 47(4), 334–337 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.